Β
November 18, 2011 β An analysis of the TRITON-TIMI 38 trial presented today in an oral session at the American Heart ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 18, 2011
November 16, 2011 β Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to ...
November 16, 2011November 16, 2011 β Non-adherence to antiplatelet therapy β which prevents blood clots following percutaneous coronary ...
November 16, 2011
November 15, 2011 β A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary ...
November 15, 2011
November 15, 2011 β A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet ...
November 15, 2011
November 15, 2011 β Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...
November 15, 2011
November 15, 2011 β Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was ...
November 15, 2011
November 11, 2011 β The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
November 11, 2011November 9, 2011 β AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 09, 2011
November 9, 2011 β Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 09, 2011
October 24, 2011 β A new study demonstrates that angiotensin-converting enzyme (ACE) inhibitors taken in the first ...
October 24, 2011
October 24, 2011 β The American College of Cardiology (ACC) announced it is expanding its outpatient PINNACLE Registry ...
October 24, 2011October 4, 2011 β Roche announced plans today to expand its coagulation testing product line in North America beyond ...
October 04, 2011
September 28, 2011 β A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in ...
September 28, 2011September 15, 2011 β The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first ...
September 16, 2011Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now